Menu
This security has been delisted
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

House Of Hr Group B.v.

WKN: A3LB6J / Name: House Of Hr Group B.v. / Stock / ? /

€93.12
-0.100%

H&R Block Inc.

WKN: 859376 / Symbol: HRB / Name: H&R Block / Stock / Personal &Household Products & Services / Mid Cap /

€26.20
0.770%

Haier Electronics Group Corp Ltd

WKN: A0MJ98 / Symbol: HRELF / Name: Haier Electronics / Stock / Household Goods / Large Cap /

€3.81
-

Heron Therapeutics Inc.

WKN: A1XB6K / Symbol: HRTX / Name: Heron Inc / Stock / Biotechnology & Medical Research / Small Cap /

€1.02
0.490%

HKR International Ltd

WKN: 877147 / Symbol: HRKIF / Name: HKR International / Stock / Real Estate Operations / Small Cap /

€0.11
0.900%

Healthcare Realty Trust

WKN: 886627 / Symbol: HR / Name: Healthcare Real / Stock / Residential & Commercial REIT / Mid Cap /

€23.40
-0.850%

Hormel Foods Corp.

WKN: 850875 / Symbol: HRL / Name: Hormel Foods / Stock / Food & Tobacco / Large Cap /

€21.24
-1.620%

Herc Holdings (HRI) Q4 Earnings Top Estimates
Herc Holdings (HRI) Q4 Earnings Top Estimates

Herc Holdings (HRI) came out with quarterly earnings of $2.07 per share, beating the Zacks Consensus Estimate of $1.84 per share. This compares to earnings of $3.58 per share a year ago. These

HRL's Pricing and Cost Actions to Support Margins in FY26
HRL's Pricing and Cost Actions to Support Margins in FY26

Hormel Foods Corporation HRL moves into fiscal 2026 with a better line of sight into its earnings trajectory after a challenging close to fiscal 2025. Management expects transitional headwinds early

Earnings Preview: Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings Expected to Decline
Earnings Preview: Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings Expected to Decline

The market expects Harmony Biosciences Holdings, Inc. (HRMY) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This

HRI or WAB: Which Is the Better Value Stock Right Now?
HRI or WAB: Which Is the Better Value Stock Right Now?

Investors interested in Transportation - Equipment and Leasing stocks are likely familiar with Herc Holdings (HRI) and Westinghouse Air Brake Technologies (WAB). But which of these two companies is

How HRL Is Reshaping Its Portfolio to Support Long-Term Growth
How HRL Is Reshaping Its Portfolio to Support Long-Term Growth

Hormel Foods Corporation HRL continues to refine its business mix as part of efforts to strengthen profitability and adapt to evolving consumer demand. The company has entered into an agreement to

Harrow (HROW) Reports Next Week: Wall Street Expects Earnings Growth
Harrow (HROW) Reports Next Week: Wall Street Expects Earnings Growth

The market expects Harrow (HROW) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook

Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings Miss Estimates
Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings Miss Estimates

Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.38 per share, missing the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.85 per share a

After Plunging 28.7% in 4 Weeks, Here's Why the Trend Might Reverse for H&R Block (HRB)
After Plunging 28.7% in 4 Weeks, Here's Why the Trend Might Reverse for H&R Block (HRB)

A downtrend has been apparent in H&R Block (HRB) lately with too much selling pressure. The stock has declined 28.7% over the past four weeks. However, given the fact that it is now in oversold

Hormel Foods (HRL) Surpasses Q1 Earnings and Revenue Estimates
Hormel Foods (HRL) Surpasses Q1 Earnings and Revenue Estimates

Hormel Foods (HRL) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.35 per share a year ago. These

Hormel (HRL) Reports Q1 Earnings: What Key Metrics Have to Say
Hormel (HRL) Reports Q1 Earnings: What Key Metrics Have to Say

For the quarter ended January 2026, Hormel Foods (HRL) reported revenue of $3.03 billion, up 1.3% over the same period last year. EPS came in at $0.34, compared to $0.35 in the year-ago quarter.

The

Heron Therapeutics (HRTX) Reports Q4 Earnings: What Key Metrics Have to Say
Heron Therapeutics (HRTX) Reports Q4 Earnings: What Key Metrics Have to Say

Heron Therapeutics (HRTX) reported $40.59 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 0.5%. EPS of -$0.02 for the same period compares to $0.02 a

Why Heritage Insurance (HRTG) Could Beat Earnings Estimates Again
Why Heritage Insurance (HRTG) Could Beat Earnings Estimates Again

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Heritage Insurance (HRTG), which belongs

Hormel (HRL) Upgraded to Buy: Here's What You Should Know
Hormel (HRL) Upgraded to Buy: Here's What You Should Know

Hormel Foods (HRL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of